Verapamil Hydrochloride Injection, Solution
Product Images NDC 51662-1398

Product Visual Gallery

This gallery contains 11 technical images submitted to the FDA as part of the official labeling for Verapamil Hydrochloride (NDC 51662-1398). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Hf Acquisition Co Llc, Dba Healthfirst, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

00351662139820 Verapamil Pouch Label

Verapamil HCI Injection is a medication that comes in a 4mL vial and has a concentration of 10mg/4mL (2.5mg/mL). It is meant for intravenous use only and should be given slowly over a period of at least two minutes. Any unused portion of the medication should be discarded. It is sterile, nonpyrogenic, and should be protected from light by retaining it in its carton until ready to use. The usual dosage should be determined based on the prescription label. The medication should be stored in a cool, dry place. The manufacturer's package insert should be consulted for more information. The medication is only available with a prescription.*

FDA Label Image

00351662139837 Verapamil Rfid Label

This appears to be a product or medication label. The provided numbers may be associated with the product's packaging, manufacturing or distribution processes. The label refers to a package insert for more information. The product has been distributed by HF Acquisition Co., LLC, based in Mukilteo, WA.*

FDA Label Image

00351662139837 Verapamil Case Label

Verapamil HCl Injection is a sterile, non-pyrogenic medication used for IV use only. It should be protected from light until ready to be used, and any unused portion should be discarded. The usual dosage should be as directed by a physician and stored at the appropriate temperature. The manufacturer is HF Acquisition Co., LLC, and the product is available in a 10 mg/4 mL (2.5 WA T TRV : Te) quantity, with NDC 51662-1398-3 and LT 12345. The product expires on 2025-D1-8. Refer to the manufacturer's package insert for additional information.*

FDA Label Image

Adverse Reactions (Adverse Reaction)

This text appears to be a medical document discussing the suggested treatments for acute cardiovascular adverse reactions. The document mentions several treatments for low-frequency adverse reactions, including dopamine intravenous, calcium chloride intravenous, and intravenous fluids. It also outlines treatments for symptomatic hypotension and bradycardia, including norepinephrine bitartrate intravenous, isoproterenol HCI intravenous, and atropine intravenous. The document also explores rapid ventricular rate and flutter/fibrillation treatment options, such as DC-cardioversion, lidocaine intravenous, and procainamide usage.*

FDA Label Image

How Supplied (How Supplied)

This appears to be a list of different quantities and packaging types for various medications with different concentrations of active ingredients, including Clamcell, SleSonanine, Shpncoraning, and EVEaLnnE, in formats such as ampoules, syringes, and vials. Each item is identified by its National Drug Code (NDC) number. No further information is available from this text.*

FDA Label Image

Logo (Logo)

FDA Label Image

Structure (Structure)

FDA Label Image

Serialized Vial Labeling (Serialized Vial)

FDA Label Image

Vial Part 1 (Vial Part 1)

FDA Label Image

Vial Laeling Part 2 (Vial Part 2)

FDA Label Image

Vial Labeling Part 3 (Vial Part 3)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.